Menu

Linoleic Acid Derivatives Potentially Mediate Pain and Itch in the Skin

Researchers uncover a family of compounds that may be involved in pain transmission.

Jan 1, 2018
Katarina Zimmer

OMEGA-6 FIELDS: Linoleic acid is plentiful in soy and other common components of modern Western diets.© ISTOCK.COM/SCALATORE1959

EDITOR'S CHOICE IN CELL AND MOLECULAR BIOLOGY

The paper
C.E. Ramsden et al., “A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch,” Sci Signal, doi:10.1126/scisignal.aal5241, 2017.

Pluses and Minuses
Linoleic acid, also known as omega-6 fatty acid—abundant in many vegetable and seed oils—is essential for forming our skin’s waxy, waterproof barrier, and has become an increasingly common component of modern Western diets. Research has linked it to pain and chronic headaches, and Christopher Ramsden, a nutrition researcher at the National Institute on Aging, wanted to know why.

Scratching the Itch
Ramsden and colleagues explored eight linoleic acid derivatives in human and rat skin. They prospected for the compounds in inflamed psoriatic skin lesions in humans, and injected them into mice to see if they would induce itching.

Feeling Pain
One of the derivatives was significantly more concentrated in psoriatic skin than in healthy skin, and induced scratching in mice. Two of the other compounds sensitized rat sensory neurons in vitro, supporting the hypothesis that such molecules could spark pain sensations. “That’s the first step in feeling itch or pain,” explains Ramsden. In line with this, when the researchers analyzed data from a clinical trial that had tested strategies to manage chronic headache, they found that patients reported fewer painful episodes when they cut back their intake of linoleic acid.

Molecular Mystery
The receptors that bind these derivatives, once identified, might provide novel pharmacological targets for treating pain. Tamara Rosenbaum, who studies pain at the National Autonomous University of Mexico and who was not involved in the study, tells The Scientist in an email that a lot of work is still needed to understand the molecular mechanisms at play, but that the study “provides us with important pieces to a puzzle.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.